BioInvent International (Sweden) Buy Hold or Sell Recommendation
| BINV Stock | SEK 23.95 2.45 11.40% |
Assuming the 90 days trading horizon and your below-average risk tolerance, our recommendation regarding BioInvent International AB is 'Hold'. Macroaxis provides BioInvent International buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BINV positions. The advice algorithm takes into account all of BioInvent International's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting BioInvent International's buy or sell advice are summarized below:
Real Value 21.79 | Hype Value 23.95 | Market Value 23.95 | Naive Value 25.24 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell BioInvent International AB given historical horizon and risk tolerance towards BioInvent International. When Macroaxis issues a 'buy' or 'sell' recommendation for BioInvent International AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
BioInvent |
Execute BioInvent International Buy or Sell Advice
The BioInvent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on BioInvent International AB. Macroaxis does not own or have any residual interests in BioInvent International AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute BioInvent International's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Solid | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
BioInvent International Trading Alerts and Improvement Suggestions
| The company reported the revenue of 19.38 M. Net Loss for the year was (278.44 M) with profit before overhead, payroll, taxes, and interest of 19.38 M. | |
| BioInvent International AB has accumulated about 28.46 M in cash with (245.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies |
BioInvent International Returns Distribution Density
The distribution of BioInvent International's historical returns is an attempt to chart the uncertainty of BioInvent International's future price movements. The chart of the probability distribution of BioInvent International daily returns describes the distribution of returns around its average expected value. We use BioInvent International AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of BioInvent International returns is essential to provide solid investment advice for BioInvent International.
| Mean Return | 0.54 | Value At Risk | -2.95 | Potential Upside | 4.50 | Standard Deviation | 2.71 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of BioInvent International historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
BioInvent International Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to BioInvent International or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that BioInvent International's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a BioInvent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.56 | |
β | Beta against NYSE Composite | -0.5 | |
σ | Overall volatility | 2.70 | |
Ir | Information ratio | 0.17 |
BioInvent International Volatility Alert
BioInvent International AB has relatively low volatility with skewness of 1.63 and kurtosis of 4.82. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure BioInvent International's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact BioInvent International's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.BioInvent International Fundamentals Vs Peers
Comparing BioInvent International's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze BioInvent International's direct or indirect competition across all of the common fundamentals between BioInvent International and the related equities. This way, we can detect undervalued stocks with similar characteristics as BioInvent International or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of BioInvent International's fundamental indicators could also be used in its relative valuation, which is a method of valuing BioInvent International by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare BioInvent International to competition |
| Fundamentals | BioInvent International | Peer Average |
| Return On Equity | -0.0274 | -0.31 |
| Return On Asset | -0.0192 | -0.14 |
| Profit Margin | (0.14) % | (1.27) % |
| Operating Margin | (0.16) % | (5.51) % |
| Current Valuation | 1.16 B | 16.62 B |
| Shares Outstanding | 65.8 M | 571.82 M |
| Shares Owned By Insiders | 11.10 % | 10.09 % |
| Shares Owned By Institutions | 57.02 % | 39.21 % |
| Price To Earning | (9.49) X | 28.72 X |
| Price To Book | 1.40 X | 9.51 X |
| Price To Sales | 7.25 X | 11.42 X |
| Revenue | 19.38 M | 9.43 B |
| Gross Profit | 19.38 M | 27.38 B |
| EBITDA | (263.32 M) | 3.9 B |
| Net Income | (278.44 M) | 570.98 M |
| Cash And Equivalents | 28.46 M | 2.7 B |
| Cash Per Share | 0.08 X | 5.01 X |
| Total Debt | 21.53 M | 5.32 B |
| Debt To Equity | 22.00 % | 48.70 % |
| Current Ratio | 2.73 X | 2.16 X |
| Book Value Per Share | 25.92 X | 1.93 K |
| Cash Flow From Operations | (245.84 M) | 971.22 M |
| Earnings Per Share | (4.55) X | 3.12 X |
| Target Price | 81.0 | |
| Number Of Employees | 93 | 18.84 K |
| Beta | 0.3 | -0.15 |
| Market Capitalization | 1.99 B | 19.03 B |
| Total Asset | 1.45 B | 29.47 B |
| Working Capital | 28 M | 1.48 B |
| Current Asset | 56 M | 9.34 B |
| Current Liabilities | 28 M | 7.9 B |
| Z Score | 55.2 | 8.72 |
| Net Asset | 1.45 B |
BioInvent International Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as BioInvent . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About BioInvent International Buy or Sell Advice
When is the right time to buy or sell BioInvent International AB? Buying financial instruments such as BioInvent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having BioInvent International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out BioInvent International Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for BioInvent Stock analysis
When running BioInvent International's price analysis, check to measure BioInvent International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioInvent International is operating at the current time. Most of BioInvent International's value examination focuses on studying past and present price action to predict the probability of BioInvent International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioInvent International's price. Additionally, you may evaluate how the addition of BioInvent International to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |